Mason Tenaglia

Mason Tenaglia has been an advisor to senior management in the Biopharmaceutical business for more than 35 years since starting his career at McKinsey & Company. Mason has worked with nearly every major pharmaceutical company in the U.S. as well as consumer health, health insurance and pharmacy benefit management companies. Prior to his recent retirement from IMS Health, Mason has built and led a number of strategy consulting firms including the Amundsen Group which was acquired by IMS in 2013. Mason is a member the Research Institute Advisory Board of Massachusetts General Hospital, has spent ten years on the advisory board of the Pharmaceutical Executive and is a frequent author and speaker on drug pricing and patient access to pharmaceuticals. He holds a BS degree in International Economics from the Walsh School of Foreign Service at Georgetown University, and an MBA in Finance and International Business from the University of Chicago.